Table 3.
Transcriptional regulators in ferroptosis
Transcription factor | Effects | Targets | Mechanism of action | Ref |
---|---|---|---|---|
ATF3 | Downregulation | SLC7A11 | Enhances ferroptosis induced by erastin through inhibiting cystine import in HT1080 and RPE cells | [230] |
ATF4 | Upregulation | HSPA5 | Suppresses ferroptosis induced by erastin and sulfasalazine in PANC-1 and CFPAC-1 cells, as well as induced by dihydroartemisinin in U251 and U373 cells, through inhibiting GPX4 degradation | [142,231] |
Upregulation | SLC7A11 | Suppresses ferroptosis induced by sorafenib or erastin in U87 cells | [232] | |
Upregulation | CHAC1 | Enhances ferroptosis induced by artesunate in CA-46 cells, as well as induced by cystine starvation in MDA-MB-231, Hs 578 T, and HCC 1937 cells, through promoting GSH degradation | [233,234] | |
ARNTL | Downregulation | EGLN2 | Suppresses ferroptosis through activation of HIF1A in HT1080 and Calu-1 cells | [177] |
Upregulation | SLC7A11, GPX4, SOD1, TXN, NFE2L2, CHMP5 | Suppresses ferroptosis through promoting antioxidant or membrane repair systems in mouse pancreas cells | [179] | |
BACH1 | Downregulation | SLC7A11, GCLM, FTH1, FTL, SLC40A1 | Enhances ferroptosis induced by erastin through repressing the transcription of GSH/iron metabolism in MEFs | [235] |
ΔNp63α (TP63) | Upregulation | GCLC, GSS, IDH2, GPX2 | Suppresses ferroptosis through promoting GSH synthesis in MEFs | [236] |
HIC1 | Upregulation | HBA1, NNMT, PLIN4 | Enhances ferroptosis induced by erastin through inhibiting GSH synthesis in HepG2 and Bel-7402 cells | [237] |
HIF1A | Upregulation | FABP3, FABP7 | Suppresses ferroptosis induced by RSL3 or FIN56 through promoting lipid storage in HT1080 and Calu-1 cells | [177] |
HIF1A | Downregulation | HELLS | Enhances ferroptosis induced by erastin through promoting the expression of GLUT1, SCD1 and FADS2 in A549 and H358 cells | [76] |
EPAS1 | Upregulation | HILPDA | Enhances ferroptosis induced by ML210 or RSL3 through enriching polyunsaturated lipids in RCC4 and 786-O cells | [82,238] |
HNF4A | Upregulation | STMN1, RRM2, CAPG | Suppresses ferroptosis induced by erastin through promoting GSH synthesis in HepG2 and Bel-7402 cells | [237] |
HSF1 | Upregulation | HSPB1 | Suppresses ferroptosis induced by erastin through reducing iron levels in HeLa, U2OS, and LNCaP cells | [239] |
JUN (OGlcNAcylated) | Upregulation | PSAT1, CBS | Suppresses ferroptosis induced by erastin through promoting GSH synthesis in Bel-7402 and SMMC-7721 cells | [240] |
MTF1 | Upregulation | FTH1, FTL, SLC40A1 | Suppresses ferroptosis induced by erastin through inhibiting iron accumulation in MDA-MB-231 cells | [241] |
NFE2L2 | Upregulation | FTH1, SLC40A1, HMOX1, MT1G | Suppresses ferroptosis through regulating iron metabolism | [50,153–155,198,205] |
NFE2L2 | Upregulation | SLC7A11, CBS, GCLM, CHAC1, ABCC1 | Suppresses ferroptosis through regulating GSH metabolism | [156–158,198,242,243] |
NFE2L2 | Upregulation | NQO1, TXNRD1, AKR1Cs, SESN2, GSTP1 | Suppresses ferroptosis through induction of detoxification or antioxidation enzymes | [50,154,155,243,244] |
SP1 | Upregulation | GPX4 | Suppresses ferroptosis induced by hemin through inhibiting lipid peroxidation in primary cortical neurons and a hemorrhagic stroke model | [30] |
Upregulation | ACSL4 | Enhances ferroptosis in ischemia/reperfusion injury | [245] | |
STAT1 | Downregulation | SLC7A11 | Enhances ferroptosis induced by IFNG through inhibiting cystine import in HT1080 cells | [210] |
STAT3 | Downregulation | ACSL4 | Suppresses ferroptosis through inhibiting lipid peroxidation in MCF10-A cells | [246] |
STAT3 | Upregulation | CSTB | Enhances ferroptosis induced by erastin or sorafenib through promoting lysosomal cell death in PANC-1 and CFPAC-1 cells | [222] |
TFAP2C | Upregulation | GPX4 | Suppresses ferroptosis induced by hemin through inhibiting lipid peroxidation in primary cortical neurons and a hemorrhagic stroke model | [30] |
TFEB | Upregulation | SOD1 | Suppresses ferroptosis induced by erastin through inhibiting lipid peroxidation in RAW264.7 cells | [247] |
TP53 | Downregulation | SLC7A11 | Enhances ferroptosis induced by erastin through inhibiting cystine import in MEFs and H1299 cells | [147] |
TP53 | Upregulation | SAT1 | Enhances ferroptosis induced by t-BuOOH through promoting SAT1-ALOX12 axis in MEFs and H1299 cells | [151] |
TP53 | Upregulation | GLS2 | Enhances ferroptosis through promoting the glutaminolysis pathway | [101] |
TP53 | Inhibition of activity | DPP4 | Suppresses ferroptosis induced by erastin through inhibiting DPP4-NOX1 axis in HCT116 and SW48 cells | [108] |
TP53 | Upregulation | CDKN1A | Suppresses ferroptosis in MEFs and HT1080 cells | [150] |
WWTR1 | Upregulation | EMP1 | Enhances ferroptosis induced by erastin through promoting NOX4-dependent lipid peroxidation in RCC4 and 786-O cells | [109] |
WWTR1 | Upregulation | ANGPTL4 | Enhances ferroptosis induced by cysteine deprivation through promoting CYBB-dependent lipid peroxidation in CAOV2 and TOV-21 G cells | [110] |
YAP1 | Upregulation | TFRC, ACSL4 | Enhances ferroptosis induced by cysteine deprivation through promoting iron-dependent lipid peroxidation in HCT116 cells | [160] |